Cargando…
The role of an in-house audit group as an innovative tool to review clinical trials
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659190/ http://dx.doi.org/10.1186/1745-6215-16-S2-O50 |
| _version_ | 1782402588275113984 |
|---|---|
| author | Trivedi, Shivali Hathi, Krishna Aslam, Natasha Saleem, Nausheen Gyertson, Kylie Whelan, Jeremy |
| author_facet | Trivedi, Shivali Hathi, Krishna Aslam, Natasha Saleem, Nausheen Gyertson, Kylie Whelan, Jeremy |
| author_sort | Trivedi, Shivali |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4659190 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46591902015-11-30 The role of an in-house audit group as an innovative tool to review clinical trials Trivedi, Shivali Hathi, Krishna Aslam, Natasha Saleem, Nausheen Gyertson, Kylie Whelan, Jeremy Trials Oral Presentation BioMed Central 2015-11-16 /pmc/articles/PMC4659190/ http://dx.doi.org/10.1186/1745-6215-16-S2-O50 Text en Copyright © 2015 Trivedi et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Trivedi, Shivali Hathi, Krishna Aslam, Natasha Saleem, Nausheen Gyertson, Kylie Whelan, Jeremy The role of an in-house audit group as an innovative tool to review clinical trials |
| title | The role of an in-house audit group as an innovative tool to review clinical trials |
| title_full | The role of an in-house audit group as an innovative tool to review clinical trials |
| title_fullStr | The role of an in-house audit group as an innovative tool to review clinical trials |
| title_full_unstemmed | The role of an in-house audit group as an innovative tool to review clinical trials |
| title_short | The role of an in-house audit group as an innovative tool to review clinical trials |
| title_sort | role of an in-house audit group as an innovative tool to review clinical trials |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659190/ http://dx.doi.org/10.1186/1745-6215-16-S2-O50 |
| work_keys_str_mv | AT trivedishivali theroleofaninhouseauditgroupasaninnovativetooltoreviewclinicaltrials AT hathikrishna theroleofaninhouseauditgroupasaninnovativetooltoreviewclinicaltrials AT aslamnatasha theroleofaninhouseauditgroupasaninnovativetooltoreviewclinicaltrials AT saleemnausheen theroleofaninhouseauditgroupasaninnovativetooltoreviewclinicaltrials AT gyertsonkylie theroleofaninhouseauditgroupasaninnovativetooltoreviewclinicaltrials AT whelanjeremy theroleofaninhouseauditgroupasaninnovativetooltoreviewclinicaltrials AT trivedishivali roleofaninhouseauditgroupasaninnovativetooltoreviewclinicaltrials AT hathikrishna roleofaninhouseauditgroupasaninnovativetooltoreviewclinicaltrials AT aslamnatasha roleofaninhouseauditgroupasaninnovativetooltoreviewclinicaltrials AT saleemnausheen roleofaninhouseauditgroupasaninnovativetooltoreviewclinicaltrials AT gyertsonkylie roleofaninhouseauditgroupasaninnovativetooltoreviewclinicaltrials AT whelanjeremy roleofaninhouseauditgroupasaninnovativetooltoreviewclinicaltrials |